Cutaneous Eruptions and Lifileucel/Interleukin 2 in Individuals With Metastatic Melanoma.
Saved in:
| Title: | Cutaneous Eruptions and Lifileucel/Interleukin 2 in Individuals With Metastatic Melanoma. |
|---|---|
| Authors: | Said JT; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Dermatology, Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts., Li Y; Department of Dermatology, Massachusetts General Hospital, Boston.; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts., Sadeghi N; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Department of Dermatology, Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts., Sullivan R; Harvard Medical School, Boston, Massachusetts.; Medical Oncology, Mass General Cancer Center, Boston, Massachusetts., Lawrence D; Harvard Medical School, Boston, Massachusetts.; Medical Oncology, Mass General Cancer Center, Boston, Massachusetts., Haugh A; Harvard Medical School, Boston, Massachusetts.; Medical Oncology, Mass General Cancer Center, Boston, Massachusetts., Boland G; Harvard Medical School, Boston, Massachusetts.; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Boston.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge., Cohen S; Harvard Medical School, Boston, Massachusetts.; Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Boston.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge., Buchbinder E; Harvard Medical School, Boston, Massachusetts.; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Liu D; Harvard Medical School, Boston, Massachusetts.; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cornejo K; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Boston., LeBoeuf NR; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Cutaneous Oncology Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts.; Harvard Data Science Initiative, Harvard University, Boston, Massachusetts. |
| Source: | JAMA dermatology [JAMA Dermatol] 2026 Jun 01; Vol. 162 (6), pp. 607-612. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
